Page last updated: 2024-10-22

acetazolamide and Pancreatic Diseases

acetazolamide has been researched along with Pancreatic Diseases in 2 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Pancreatic Diseases: Pathological processes of the PANCREAS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
POPPER, HL1
SPORN, J1
LEVINSON, M1
NECHELES, H1
Raptis, S1
Dollinger, H1
Rothenbuchner, G1
Fussgänger, R1
Klör, U1
Pfeiffer, EF1

Other Studies

2 other studies available for acetazolamide and Pancreatic Diseases

ArticleYear
Prevention of pancreatic fat necrosis. IV. Experiments with carbonic anhydrase inhibitor (diamox).
    The American journal of physiology, 1955, Volume: 181, Issue:1

    Topics: Acetazolamide; Biomedical Research; Carbonic Anhydrase Inhibitors; Disease; Diuretics; Fat Necrosis;

1955
Effect of acetazolamide on the insulin response to intravenous administration of secretin.
    Nutrition and metabolism, 1974, Volume: 16, Issue:2

    Topics: Acetazolamide; Antigens; Bicarbonates; Blood Glucose; Chronic Disease; Drug Synergism; Duodenum; Fat

1974